Crohn’s Disease Market Share, Size, Growth, Trends, Analysis, Research and Forecast - 2030
The Crohn’s Disease market size was valued at USD 11.1 billion in 2022 and is projected to grow from USD 11.5 Billion in 2023 to USD 15.37 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.7% during the forecast period (2023 - 2032).
Crohn's disease is a type of inflammatory bowel
disease (IBD), caused by a combination of environmental, immune, and bacterial
factors in genetically prone individuals. There are no medications, drugs or
surgical procedures that can cure or prevent Crohn's disease. It is expected
that the disease affects about 3.2 per 1,000 people in Europe and North
America. It is less common in Asia and Africa. Rates have, however, been
growing, particularly in the developing world, since last few years.
The Crohn’s & Colitis Foundation of America
(CCFA) stated that over 1 million Americans were diagnosed with Crohn's &
ulcerative colitis disorders and diseases, with maximum of them aged above 30.
Increasing occurrence of Crohn's disease market has triggered
a vigorous demand for its therapeutics. A survey conducted by the US Centre for
Disease Control (CDC) has discovered that the incidence rate of Crohn's disease
in the country is 3.1 to 14.6 new cases per 100,000 population annually.
North
America is expected to account for the largest share of the global Crohn’s disease Market report in 2016, followed by Europe, the region will
continue to lead the pack during the forecast period. The emerging markets of
China and India will also play a key role in driving growth in the long term,
primarily due to the anticipated strong uptake of Remicade over the forecast
period.
The disease is highly predominant in developed
countries, especially in individuals who smoke and consume alcohol.
Major factors leading to the growth of the
market includes higher preference for symptomatic therapeutic, better treatment
of inflammatory bowel diseases, arrival of enhanced drugs and healthier
investments in R&D programs. High cost of treatment and lack of early
diagnosis techniques are the major factor restricting the market growth.
Market Segmentation:
Global Crohn’s Disease Market is segmented
based on procedures and drug type. Based on procedures, the market is segmented
into Colonoscopy, flexible Sigmoidoscopy, Computerized Tomography (CT), surface coil magnetic resonance imaging (MRI), Capsule Endoscopy,
Double-Balloon Endoscopy, Small Bowel Imaging. Colonoscopy due to high
efficiency and accuracy is expected to command the largest market share during
the forecasted period. Further based on drug type the market is classified into
antibiotics, anti-diarrheal, immune system suppressors, pain relievers, and
anti-inflammatory drugs. Antibiotics are expected to command the largest market
share while anti-inflammatory drugs are expected to grow at the highest CAGR
during the forecasted period.
Crohn’s
Disease Market Players
The Crohn’s
disease market players
profiled in the report are Allergan, Inc., AbbVie Inc., Takeda Pharmaceutical
Company Limited, and Bayer AG, UCB S.A., Perrigo Company plc, Pfizer Inc.,
Johnson & Johnson Services, Inc., Ferring B.V.
About Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment